EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Antibiotic Prescribing for Group B Streptococcus Coverage in Preterm Prelabour Rupture of Membranes: A Retrospective Cohort Study

Elaf Abuelgasim, Mark McIntyre, Najla Tabbara

Pharmacoepidemiology · 07.03.2026 · 5 (1) · 8

DOI: 10.3390/pharma5010008 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pharmacoepidemiology, online erschienen am 07.03.2026. Verfasst von Elaf Abuelgasim und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preterm prelabour rupture of membranes (PPROM) is the spontaneous rupture of fetal membranes prior to 37 weeks of pregnancy. Latency antibiotics, including macrolides with or without group B streptococcus (GBS)-covering antibiotics, are recommended as part of expectant management. Currently, there is no consensus on whether GBS-covering antibiotics should be prescribed. The primary objective of this retrospective cohort study was to characterize practice variation in GBS-covering antibiotic prescribing in PPROM. The secondary objective was to explore the association between maternal characteristics and GBS-covering antibiotic prescribing.

Methods

Pregnant women with PPROM prescribed azithromycin (institutional standard antibiotic regimen) in 2024 and not in active labour were included. Maternal characteristics, stratified by GBS status, were compared. The association between antibiotic prescribing for GBS coverage and maternal factors was assessed using odds ratios. Two-sided p-values < 0.05 were considered statistically significant.

Results

Out of the 181 admissions assessed for eligibility, 146 patients were included. Their GBS status at PPROM diagnosis was negative (19/146; 13%), positive (8/146; 5%), or unknown (119/146; 82%). The frequency of GBS-covering antibiotics prescribing was 5/8 (63%) in the positive group, 4/19 (21%) in the negative group, and 65/119 (55%) in those with an unknown GBS status. Aminopenicillin-based and penicillin regimens accounted for (69/74; 93%) of antibiotic regimens. Half (38/74; 51%) of the GBS-covering antibiotics were prescribed for 3–7 days, with a 33/74 (45%) completion rate as prescribed at PPROM diagnosis. The main reason for antibiotic discontinuation was negative GBS recto-vaginal swabs or urine cultures collected in those with an unknown GBS status at PPROM diagnosis, highlighting the role of microbiology laboratory testing in adjusting antibiotic therapy and facilitating antimicrobial stewardship. Aside from GBS status, no maternal characteristics were associated with GBS-covering antibiotic prescribing.

Conclusions

At PPROM diagnosis, GBS coverage was prescribed in 21%, 63%, and 55% of patients with a negative, positive, and unknown GBS status, respectively. Only GBS status was associated with GBS-covering antibiotic prescribing. Further research is required to determine the impact of GBS coverage on perinatal outcomes.

Zitieren

APA

Abuelgasim, E., McIntyre, M., & Tabbara, N. (2026). Antibiotic Prescribing for Group B Streptococcus Coverage in Preterm Prelabour Rupture of Membranes: A Retrospective Cohort Study. Pharmacoepidemiology, 5(1), 8. https://doi.org/10.3390/pharma5010008

Vancouver

Abuelgasim E, McIntyre M, Tabbara N. Antibiotic Prescribing for Group B Streptococcus Coverage in Preterm Prelabour Rupture of Membranes: A Retrospective Cohort Study. Pharmacoepidemiology. 2026;5(1):8. doi:10.3390/pharma5010008

BibTeX
@article{Abuelgasim2026,
  author = {Abuelgasim, Elaf and McIntyre, Mark and Tabbara, Najla},
  title = {Antibiotic Prescribing for Group B Streptococcus Coverage in Preterm Prelabour Rupture of Membranes: A Retrospective Cohort Study},
  journal = {Pharmacoepidemiology},
  year = {2026},
  volume = {5},
  number = {1},
  pages = {8},
  doi = {10.3390/pharma5010008}
}
Kostenlos starten →